AMERSCAN MEDRONATE II DIN 02328798
Health Canada record
| Active ingredient(s) | MEDRONATE SODIUM 6.3 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 02-Sep-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
GE Healthcare Canada Inc. — licence 101469, currently licensed, last inspection rating C (2023-02-06).
No Canadian shortage report is currently matched to this DIN.
Request a quote for AMERSCAN MEDRONATE II